Anti-Somatostatin Receptor 2 antibody [UMB1]

• Supplier: Abcam
• Catalog: ab134152
• Prices: $392.00
• Sizes: 100 µl
• Host: Rabbit
• Clonality: Monoclonal
• Isotype: IgG
• Clone: UMB1
• Applications: WB IP IHC-P
• Species Reactivities: Mouse, Rat, Human
• Antigen: Synthetic peptide corresponding to residues on the C-terminal of Human Somatostatin Receptor 2 (P30874)
• Blocking Peptide: Somatostatin Receptor 2 peptide
• Description: Rabbit Monoclonal
• Gene: SSTR2
• Conjugate: Unconjugated

Product images

All lanes : Anti-Somatostatin Receptor 2 antibody [UMB1] (ab134152) at 1/1000 dilutionLane 1 : U937 cell lysatesLane 2 : INS-1 cell lysatesLane 3 : sstr2 transfected HEK293 cell lysatesLysates/proteins at 10 µg per lane.SecondaryHRP labelled goat anti-rabbit at 1/2000 dilution

Immunohistochemical analysis of paraffin embedded Human pancreas tissue labelled with ab134152 at 1/100 dilution.

Immunohistochemical analysis of paraffin embedded Human brain tissue labelled with ab134152 at 1/100 dilution.

Product References

Carboxyl-terminal receptor domains control the differential dephosphorylation of - Carboxyl-terminal receptor domains control the differential dephosphorylation of

Lehmann A, Kliewer A, Martens JC, Nagel F, Schulz S. PLoS One. 2014 Mar 17;9(3):e91526.

Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE - Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE

Clifton-Bligh RJ, Hofman MS, Duncan E, Sim IeW, Darnell D, Clarkson A, Wong T, Walsh JP, Gill AJ, Ebeling PR, Hicks RJ. J Clin Endocrinol Metab. 2013 Feb;98(2):687-94.

Somatostatin receptor type 2 antagonism improves glucagon counterregulation in - Somatostatin receptor type 2 antagonism improves glucagon counterregulation in

Karimian N, Qin T, Liang T, Osundiji M, Huang Y, Teich T, Riddell MC, Cattral MS, Coy DH, Vranic M, Gaisano HY. Diabetes. 2013 Aug;62(8):2968-77.

Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor - Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor

Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, Ranchere-Vince D, Decouvelaere AV, de la Fouchardiere A, Gill AJ. Hum Pathol. 2013 Dec;44(12):2711-8.

Illuminating somatostatin analog action at neuroendocrine tumor receptors. - Illuminating somatostatin analog action at neuroendocrine tumor receptors.

Reubi JC, Schonbrunn A. Trends Pharmacol Sci. 2013 Dec;34(12):676-88.

Free somatostatin receptor fraction predicts the antiproliferative effect of - Free somatostatin receptor fraction predicts the antiproliferative effect of

Heidari P, Wehrenberg-Klee E, Habibollahi P, Yokell D, Kulke M, Mahmood U. Cancer Res. 2013 Dec 1;73(23):6865-73.

Comparing of IRS and Her2 as immunohistochemical scoring schemes in - Comparing of IRS and Her2 as immunohistochemical scoring schemes in

Kaemmerer D, Peter L, Lupp A, Schulz S, Sanger J, Baum RP, Prasad V, Hommann M. Int J Clin Exp Pathol. 2012;5(3):187-94. Epub 2012 Mar 25.

Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells - Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells

Lecolle K, Begard S, Caillierez R, Demeyer D, Grellier E, Loyens A, Csaba Z, Beauvillain JC, D'Halluin JC, Baroncini M, Lejeune JP, Sharif A, Prevot V, Dournaud P, Buee L, Colin M. Gene Ther. 2013 Mar;20(3):283-97.

Structural determinants of agonist-selective signaling at the sst(2A) - Structural determinants of agonist-selective signaling at the sst(2A)

Nagel F, Doll C, Poll F, Kliewer A, Schroder H, Schulz S. Mol Endocrinol. 2011 May;25(5):859-66.

Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin - Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin

Poll F, Lehmann D, Illing S, Ginj M, Jacobs S, Lupp A, Stumm R, Schulz S. Mol Endocrinol. 2010 Feb;24(2):436-46.